Integral Health Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Integral Health Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.6M	Buy	1,900,000 +500,000	+36%	+$4.53M	0.81%	36
2026 Q1	$17.7M	Buy	1,400,000 +200,000	+17%	+$2.27M	0.85%	30
2025 Q4	$9.82M	Buy	1,200,000 +300,000	+33%	+$3.45M	0.49%	59
2025 Q3	$10.8M	Sell	900,000 -350,000	-28%	-$3.68M	0.73%	49
2025 Q2	$12.7M	Buy	+1,250,000	New	+$8.39M	1.16%	30

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Integral Health Asset Management's ORIC Position: Q2 2026 in Review

Integral Health Asset Management increased its Oric Pharmaceuticals (ORIC) stake by 36% in Q2 2026, buying an estimated $4.53M and bringing the position to 1,900,000 shares worth $20.6M. The position accounts for 0.81% of the portfolio, ranked #36.

Integral Health Asset Management first reported a position in ORIC in Q2 2025 and has held it in 5 quarters since. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Integral Health Asset Management held 1,900,000 shares of Oric Pharmaceuticals worth $20.6M as of Q2 2026.
Integral Health Asset Management bought 500,000 Oric Pharmaceuticals shares in Q2 2026, an estimated $4.53M.
Oric Pharmaceuticals made up 0.81% of Integral Health Asset Management's portfolio in Q2 2026, its #36 holding.
Integral Health Asset Management first reported a position in Oric Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.